Start: October 2015
End: December 2017
What Is This Study About?
This study will validate Neurotrack's visual paired comparison task to determine whether this task is associated with markers of brain pathology indicating very early Alzheimer's disease.
Do I Qualify To Participate in This Study?
- Clinical diagnosis based on recent (within 1 year) consensus meeting and neuropsychological test scores
- Cognitively normal participants: cognitively normal based on Mini-Mental State Examination (MMSE), Clinical Dementia Rating (CDR), and GDS scores
- Amnestic mild cognitive impairment (aMCI) participants: diagnosis of aMCI, based on MMSE, CDR, and GDS scores
- Normal or corrected-to-normal vision and hearing (able to see images on computer screen and hear auditory events delivered through the computer speaker)
Must NOT have:
- Significant history of mental illness; clinical depression not medically controlled; drug or alcohol abuse
- Severe trauma preventing normal use of dominant hand (needed to move the computer mouse)
- Other neurologic conditions (such as stroke), learning disability, or vision problems that prevent viewing a computer screen at a normal distance, including legal blindness, detached retinas, occlusive cataracts
- Pacemaker, aneurysm clip, cochlear implant, pulse oximeter, EKG lead, tattoos, or other metal/foreign objects in body or face that preclude MRI
- Lack of capacity to give informed consent and lack of authorized representative to provide consent
- Pregnant, breastfeeding, or planning to have a baby
If I Qualify, Who Do I Contact?
Contact study personnel listed either under the general study contact or the location nearest you.
Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.
Where Is This Study Located?
Lead: New York University School of Medicine
NeuroTrack Technologies, Inc.
Source: ClinicalTrials.gov ID: NCT02608021